Phase II trial of nilotinib in PDGFR-alpha-enriched recurrent high-grade gliomas Read more about Phase II trial of nilotinib in PDGFR-alpha-enriched recurrent high-grade gliomas
CTNNA1-associated retinal dystrophy: novel multimodal imaging and electrophysiology features Read more about CTNNA1-associated retinal dystrophy: novel multimodal imaging and electrophysiology features
Transdifferentiation of Multiple Myeloma into Histiocytic Sarcoma: Case Report of a Highly Unusual Phenomenon Read more about Transdifferentiation of Multiple Myeloma into Histiocytic Sarcoma: Case Report of a Highly Unusual Phenomenon
Ring Chromosomes in Patients with Myeloid Neoplasms Are Associated with a Poor Response to Therapy Read more about Ring Chromosomes in Patients with Myeloid Neoplasms Are Associated with a Poor Response to Therapy
Association between p16-INK4A expression and a treatment response to CDK4/6 inhibitor in advanced breast carcinoma Read more about Association between p16-INK4A expression and a treatment response to CDK4/6 inhibitor in advanced breast carcinoma
High-grade glioma with pleomorphic and pseudopapillary features: a single-institution series of three cases Read more about High-grade glioma with pleomorphic and pseudopapillary features: a single-institution series of three cases
Clonal hematopoiesis and inflammation predict hematologic toxicity and secondary myeloid malignancies after BCMA-directed chimeric antigen receptor T cell therapy Read more about Clonal hematopoiesis and inflammation predict hematologic toxicity and secondary myeloid malignancies after BCMA-directed chimeric antigen receptor T cell therapy
Safety and Efficacy of Tarlatamab in patients with Neuroendocrine Prostate Cancer: Results from the Phase 1b DeLLpro-300 Study Read more about Safety and Efficacy of Tarlatamab in patients with Neuroendocrine Prostate Cancer: Results from the Phase 1b DeLLpro-300 Study
First-in-Human Phase 1/2 Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors. Read more about First-in-Human Phase 1/2 Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors.
Genomic Profiles of Early-Stage Non-Small Cell Lung Cancer Patients, and Association with Pre-Treatment Blood Circulating Tumor DNA Detection and Levels Read more about Genomic Profiles of Early-Stage Non-Small Cell Lung Cancer Patients, and Association with Pre-Treatment Blood Circulating Tumor DNA Detection and Levels